Thermo Fisher Scientific TMO

Marc N. Casper will become Chairman and Chief Executive Officer, effective March 1, 2026. Mr. Marc N. Casper ,Thermo Fisher Scientific Inc. Chairman, President and CEO (2020 - Present) ,President and CEO (2009 - 2020), Executive VP and COO (2008 - 2009), Executive VP (2006 - 2008) ,Synopsys, Inc. U.S. Bancorp Mr. Casper currently serves as the President and Chief Executive Officer of the Company, and over the course of his long-standing tenure with the Company, he served in various other senior level management roles.

Scott M. Sperling, Director PROFESSIONAL HIGHLIGHTS Co-Chief Executive Officer, Thomas H. Lee Partners, LP (1994 - Present) OTHER CURRENT DIRECTORSHIPS: None PREVIOUSLY HELD DIRECTORSHIPS: The Madison Square Garden Company DIRECTOR QUALIFICATIONS Mr. Sperling currently serves as Co-Chief Executive Officer of Thomas H. Lee Partners, LP (THL), a private equity firm. During his 30-year career leading THL, he has gained broad experience with the various industries represented in the THL portfolio, including healthcare and technology.

On February 19, 2025, the Board of Directors of Thermo Fisher Scientific Inc. elected Karen S. Lynch as a director of the Company, effective February 19, 2025. Ms. Lynch is a seasoned health care executive who has over three decades of experience in the industry. As the former president and chief executive officer of CVS Health Corporation (NYSE: CVS) (CVS Health), a leading health solutions company, where she was responsible for leading more than 300,000 employees. Under Ms. Lynch's leadership, CVS Health touched the lives of more than 120 million consumers through its health care benefits and pharmacy benefits management businesses, and presence in over 9,000 community health destinations across the U.S. Prior to her service as president and CEO of CVS Health, Ms. Lynch served as an Executive Vice President of CVS Health and President of Aetna, and prior to that, Ms. Lynch held a number of executive positions at Aetna Inc., a health insurance company, Magellan Health Services, a health care management company, and at Cigna Corporation, a global health insurance company. Ms. Lynch began her career as a Certified Public Accountant at the auditing firm Ernst & Young LLP, and has previously served as a board member of CVS Health and U.S. Bancorp.

Nelson J. Chai, Director. PROFESSIONAL HIGHLIGHTS; Executive Chair, DailyPay (2025 - Present) CFO, Uber Technologies Inc. (2018 - 2024) President and CEO, The Warranty Group (2017 - 2018) OTHER CURRENT DIRECTORSHIPS: Chubb Limited DIRECTOR QUALIFICATIONS Mr. Chai currently serves as the Executive Chair of DailyPay, a worktech platform. He previously served as Chief Financial Officer of Uber Technologies Inc., a ridesharing technology platform, as President and CEO of The Warranty Group, a provider of specialty insurance products, and as President of CIT Group, a financial institution.

Tyler Jacks,PROFESSIONAL HIGHLIGHTS President, Break Through Cancer (2021 - Present) Massachusetts Institute of Technology, Koch Institute Professor, Department of Biology and Center for Cancer Research (1992 - Present) Founding Director, Integrative Cancer Research (2001 - 2021) Investigator, Howard Hughes Medical Institute (1994 - 2021) OTHER CURRENT DIRECTORSHIPS: Amgen, Inc. DIRECTOR QUALIFICATIONS Dr. Jacks currently serves as President of Break Through Cancer, an organization focusing on collaborative approaches to cancer research, has worked for over 30 years as a professor in the Department of Biology at Massachusetts Institute of Technology, and previously served as Founding Director of the Koch Institute, a cancer research center.

Debora L. Spar, Director since: 2019. PROFESSIONAL HIGHLIGHTS Harvard Business School Professor and Senior Associate Dean, Business and Global Society (2021 - Present) Professor and Senior Associate Dean, Harvard Business School Online (2019 - 2021) OTHER CURRENT DIRECTORSHIPS: None PREVIOUSLY HELD DIRECTORSHIPS: Goldman Sachs and Northern Star Acquisition Corp. DIRECTOR QUALIFICATIONS Dr. Spar currently serves as a professor of Business Administration at Harvard Business School and Senior Associate Dean for Business in Global Society, and previously served as President and CEO of the Lincoln Center for the Performing Arts and as President of Barnard College.

Dion J. Weisler, PROFESSIONAL HIGHLIGHTS President and CEO, HP Inc. (2015 - 2019) OTHER CURRENT DIRECTORSHIPS: BHP, Intel Corporation and Qantas Group PREVIOUSLY HELD DIRECTORSHIPS: HP Inc. DIRECTOR QUALIFICATIONS Mr. Weisler previously served as Chief Executive Officer of HP Inc., an information technology company. Prior to that he served in various roles with increasing levels of responsibility at HP, Lenovo Group Inc., and at Telstra Corp. Lt., a telecommunications company.

PROFESSIONAL HIGHLIGHTS University of Texas, Austin, Dell Medical School (2016 - Present) Vice President of the Health Enterprise (2023 - Present) Chief Business Officer Professor, Department of Internal Medicine Interim Vice President for Medical Affairs (2021 - 2023) Associate Vice President of the Health Enterprise (2016 - 2023) OTHER CURRENT DIRECTORSHIPS: Colgate-Palmolive Company and MultiPlan Corporation PREVIOUSLY HELD DIRECTORSHIPS: HealthStream Inc. and Invacare Corporation DIRECTOR QUALIFICATIONS Dr. Harris currently serves as Chief Business Officer of Dell Medical School of the University of Texas, Austin. He has had a long-standing career as a physician and previously served as Chief Information Officer of Cleveland Clinic Hospital, and Chief Strategy Officer of the Cleveland Clinic Foundation.

Ms. Jennifer M. Johnson PROFESSIONAL HIGHLIGHTS Franklin Resources, Inc. President and CEO (2020 - Present) President and COO (2017 - 2020) OTHER CURRENT DIRECTORSHIPS: Director or trustee of certain funds registered as investment companies managed or advised by subsidiaries of Franklin Resources DIRECTOR QUALIFICATIONS Ms. Johnson currently serves as President and Chief Executive Officer of Franklin Resources, Inc., a publicly traded global investment management company.

Ruby R. Chandy, Director. PROFESSIONAL HIGHLIGHTS; President, Pall Industrial, Pall Corporation (2012 - 2015) Previously held various roles at Thermo Fisher (2001 - 2007) OTHER CURRENT DIRECTORSHIPS: DuPont de Nemours Inc. and Flowserve Corporation PREVIOUSLY HELD DIRECTORSHIPS: Ametek, Inc. DIRECTOR QUALIFICATIONS Ms. Chandy previously served as President of the Industrial Division of Pall Corporation, a leading supplier of filtration, separation and purification technologies and as Chief Marketing Officer at the Dow Chemical Company and at Rohm and Haas Corporation. Prior to that she served in various roles with increasing levels of responsibility at Thermo Fisher Scientific, Boston Scientific, and Millipore Corporation.

R. Alexandra Keith,PROFESSIONAL HIGHLIGHTS Procter & Gamble Company Chief Executive Officer, P&G Beauty (2019 - Present), and Executive Sponsor, Corporate Sustainability (2021 - Present) President, Global Hair Care and Beauty Sector (2017 - 2019) President, Global Skin and Personal Care (2014 - 2017) DIRECTOR QUALIFICATIONS Ms. Keith currently serves as Chief Executive Officer of P&G Beauty at Procter & Gamble, a global consumer products company. During her 30-plus year career at P&G, Ms. Keith served in roles in manufacturing, logistics, innovation planning, and marketing, then continued into various management and senior leadership roles. Ms. Keith also serves as Executive Sponsor for Corporate Sustainability at P&G, where she works alongside P&G's Chief Sustainability Officer to guide the company's sustainability progress.

The Company announced that the Board of Directors approved the appointment of James R. Meyer, currently Vice President, Financial Operations of the Company, as Senior Vice President and CFO of the Company, effective March 1, 2026. Mr. Meyer joined Thermo Fisher in July 2009 and has served in a number of finance roles of increasing responsibility across the Company, including as Vice President of Finance, Customer Channels from April 2020 to December 2022, before assuming his current role in January 2023. Prior to joining Thermo Fisher, Mr. Meyer worked for PricewaterhouseCoopers.

Mr. Lisa P. Britt, Senior Vice President and Chief Human Resources Officer (2017).

Joseph Holmes, Vice President and Chief Accounting Officer (2021) Senior Director, Technical Accounting (2017-2021).

Michael Shafer, currently an Executive Vice President, will be promoted to an expanded role, effective March 1, 2026. Mr. Michael D. Shafer, Executive Vice President (2024); Senior Vice President and President, Pharma Services (2019-2024); President, Materials and Structural Analysis (2016-2019).